This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4l7o
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
==Human artd3 (parp3) - catalytic domain in complex with inhibitor STO1542== | ==Human artd3 (parp3) - catalytic domain in complex with inhibitor STO1542== | ||
| - | <StructureSection load='4l7o' size='340' side='right' caption='[[4l7o]], [[Resolution|resolution]] 2.00Å' scene=''> | + | <StructureSection load='4l7o' size='340' side='right'caption='[[4l7o]], [[Resolution|resolution]] 2.00Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4l7o]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4l7o]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L7O OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4L7O FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1VD:N-{(1S)-1-[4-(1H-IMIDAZOL-1-YL)PHENYL]ETHYL}-3-(4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)PROPANAMIDE'>1VD</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1VD:N-{(1S)-1-[4-(1H-IMIDAZOL-1-YL)PHENYL]ETHYL}-3-(4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)PROPANAMIDE'>1VD</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4l7o FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l7o OCA], [https://pdbe.org/4l7o PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4l7o RCSB], [https://www.ebi.ac.uk/pdbsum/4l7o PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4l7o ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PARP3_HUMAN PARP3_HUMAN] Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks. May link the DNA damage surveillance network to the mitotic fidelity checkpoint. Negatively influences the G1/S cell cycle progression without interfering with centrosome duplication. Binds DNA. May be involved in the regulation of PRC2 and PRC3 complex-dependent gene silencing.<ref>PMID:16924674</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 21: | ||
==See Also== | ==See Also== | ||
| - | *[[Poly (ADP-ribose) polymerase|Poly (ADP-ribose) polymerase]] | + | *[[Poly(ADP-ribose) polymerase 3D structures|Poly(ADP-ribose) polymerase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: Andersson | + | [[Category: Large Structures]] |
| - | [[Category: Ekblad | + | [[Category: Andersson CD]] |
| - | [[Category: Elofsson | + | [[Category: Ekblad T]] |
| - | [[Category: Karlberg | + | [[Category: Elofsson M]] |
| - | [[Category: Lindgren | + | [[Category: Karlberg T]] |
| - | [[Category: Linusson | + | [[Category: Lindgren AEG]] |
| - | [[Category: Schuler | + | [[Category: Linusson A]] |
| - | [[Category: Spjut | + | [[Category: Schuler H]] |
| - | [[Category: Thorsell | + | [[Category: Spjut S]] |
| - | [[Category: Weigelt | + | [[Category: Thorsell AG]] |
| - | + | [[Category: Weigelt J]] | |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Human artd3 (parp3) - catalytic domain in complex with inhibitor STO1542
| |||||||||||
Categories: Homo sapiens | Large Structures | Andersson CD | Ekblad T | Elofsson M | Karlberg T | Lindgren AEG | Linusson A | Schuler H | Spjut S | Thorsell AG | Weigelt J
